Literature DB >> 20609688

Utility and limitations of the traditional diagnostic approach to hyponatremia: a diagnostic study.

Wiebke Fenske1, Sebastian K G Maier, Anne Blechschmidt, Bruno Allolio, Stefan Störk.   

Abstract

BACKGROUND: The differential diagnosis of hyponatremia is often challenging because of its association with multiple underlying pathophysiological mechanisms, diseases, and treatment options. Several algorithms are available to guide the diagnostic approach to hyponatremia, but their diagnostic and clinical utility has never been evaluated. We aimed to assess in detail the diagnostic utility as well as the limitations of the existing approaches to hyponatremia.
METHODS: Each of the 121 consecutive subjects presenting with hyponatremia (serum sodium <130 mmoL/L) underwent 3 different and independent diagnostic and therapeutic approaches: inexperienced doctor applying an established Algorithm, intensive care senior physicians acting as Senior Physician, and senior endocrinologist serving as Reference Standard.
RESULTS: The overall diagnostic agreement between Algorithm and Reference Standard was 71% (respective Cohen's kappa and delta values were 0.64 and 0.70), the overall diagnostic agreement between Senior Physician and Reference Standard was 32% (0.20 and 0.19, respectively). Regarding the therapeutic consequences, the diagnostic accuracy of the Algorithm was 86% (0.70 and 0.72, respectively) and of the Senior Physician was 48% (0.01 and 0.04, respectively). In retrospect, by disregarding the patient's extracellular fluid volume and assessing the effective arterial blood volume by determination of the fractional urate excretion, the Algorithm improved its diagnostic accuracy to 95%.
CONCLUSION: Although the Algorithm performed reasonably well, several shortcomings became apparent, rendering it difficult to apply the Algorithm without reservation. Whether some modifications may enhance its diagnostic accuracy and simplify the management of hyponatremia needs to be determined. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20609688     DOI: 10.1016/j.amjmed.2010.01.013

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  35 in total

1.  [Language of the other].

Authors:  L von Ferber
Journal:  Fortschr Med       Date:  1975-12-04

2.  [Hyponatremia: differential diagnosis and therapy].

Authors:  C S Haas
Journal:  Internist (Berl)       Date:  2014-12       Impact factor: 0.743

3.  Clinical management of SIADH.

Authors:  Peter Gross
Journal:  Ther Adv Endocrinol Metab       Date:  2012-04       Impact factor: 3.565

Review 4.  Hyponatraemia: more than just a marker of disease severity?

Authors:  Robert W Schrier; Shailendra Sharma; Dmitry Shchekochikhin
Journal:  Nat Rev Nephrol       Date:  2012-11-20       Impact factor: 28.314

Review 5.  [Hyponatremia in emergency admissions - often dangerous].

Authors:  W Fenske
Journal:  Internist (Berl)       Date:  2017-10       Impact factor: 0.743

6.  Efficacy and safety of two different tolvaptan doses in the treatment of hyponatremia in the Emergency Department.

Authors:  Luigi Mario Castello; Marco Baldrighi; Alice Panizza; Ettore Bartoli; Gian Carlo Avanzi
Journal:  Intern Emerg Med       Date:  2016-07-21       Impact factor: 3.397

7.  A prospective study to compare the clinical efficacy of Tolvaptan with 3% hypertonic saline solution in hospitalized patients having hyponatremia.

Authors:  Jobin Kunjumon Vilapurathu; S Rajarajan
Journal:  J Res Pharm Pract       Date:  2014-01

8.  Copeptin as a marker for arginine-vasopressin/antidiuretic hormone secretion in the diagnosis of paraneoplastic syndrome of inappropriate ADH secretion.

Authors:  A Wuttke; K C Dixit; G Szinnai; S C Werth; U Haagen; M Christ-Crain; N Morgenthaler; G Brabant
Journal:  Endocrine       Date:  2013-03-12       Impact factor: 3.633

9.  Stimulation of V1a receptor increases renal uric acid clearance via urate transporters: insight into pathogenesis of hypouricemia in SIADH.

Authors:  Kei Taniguchi; Yoshifuru Tamura; Takanori Kumagai; Shigeru Shibata; Shunya Uchida
Journal:  Clin Exp Nephrol       Date:  2016-03-02       Impact factor: 2.801

Review 10.  Copeptin in the diagnosis of vasopressin-dependent disorders of fluid homeostasis.

Authors:  Mirjam Christ-Crain; Wiebke Fenske
Journal:  Nat Rev Endocrinol       Date:  2016-01-22       Impact factor: 43.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.